Respiratory diseases kill.
Even before the COVID-19 pandemic 1.5 million people, including 700,000 children, died annually of pneumonia worldwide; over 4,000 every day. It is the fourth most common cause of death. Chronic Obstructive Pulmonary Disease (COPD) additionally kills 3 million people worldwide annually and is relentlessly increasing.
All these people need access to safe, reliable and effective treatment for critical respiratory illness. Increasing understanding of COVID-19 pneumonia has shown that non-invasive forms of ventilatory support, which do not require patients to be anaesthetised and intubated, are preferable and advantageous for many patients.
Exovent is a charity led by a team of eminent Anaesthetists, Critical Care Doctors, Paediatricians, Surgeons, Critical Care Nurses, Senior Engineers and Commercial Professionals. We believe that Continuous Negative Extrathoracic Pressure (CNEP), and Negative Pressure Ventilation (NPV) are valuable methods of breathing support for the treatment of acute pneumonia, including COVID-19, and chronic pulmonary disease of many types.
Read the latest from our team
Publication: ABMJ, 27th Sept 2022
Publication: Association of Anaesthetists, 25th Sept 2022
Source: Independent, 20th Jan 2021
Source: Sky News, 20th Jan 2021
Source: Daily Mail, 19th Jan 2021
Source: Evening Express, 19th Jan 2021
Source: The Engineer, 2nd April 2021
Source: ENT & Audiology News, 3rd Sept 2021
Source: Institute of Mechanical Engineers, 13th Dec 2021
CONTACT US: The team at Exovent are incredibly knowledgeable due to their breadth and depth of experience. We are always keen to share our knowledge, experience, and thought. To find out even more, or to join us on this journey, please contact us.